Keynote Speakers
Saumya Das
Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital | 
Anindya Dutta
Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine | 
Steven Pirie-Shepherd
Director, Pfizer | 
Walter Koch
Vice President, Roche Molecular Systems | 
Jennifer Jones
Staff Clinician, National Cancer Institute (NCI) | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas |
|
.png)
Gyongyi Szabo
Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School | 
Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic | 
Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University | 
Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School | 
David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles | 
Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School | 
Balaji Panchapakesan
Associate Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI) | 
Mike Makrigiorgos
Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School | 
Paul Robbins
Professor, The Scripps Research Institute | 
George Calin
Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center | 
Jan Lötvall
Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences; Founding President of ISEV | 
Cha-Mei Tang
President and CEO, Creatv MicroTech | 
Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington | 
J. Carl Barrett
Vice President, Translational Sciences Oncology, AstraZeneca | 
Cheng-Ho Jimmy Lin
Chief Scientific Officer, Natera | 
Tony Jun Huang
Professor of Mechanical Engineering and Materials Science (MEMS), Pratt School of Engineering, Duke University | 
Bob Carter
Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School |
OverviewSelect Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various classes of circulating biomarkers and their emerging applications: - Extracellular Vesicles (EVs): Exosomes and Microvesicles
- Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
- Circulating Cells in the Circulation (Circulating Tumor Cells and Cancer Stem Cells)
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies from around the world providing tools/technologies, products and services addressing the circulating biomarkers field.
Agenda and Information for:
|
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonCirculating Biomarkers World Congress 2018Circulating Biomarkers World Congress 2018 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
